PA
CDNA icon

Profund Advisors’s CareDx CDNA Stock Holding History

Profund Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Sell
16,518
-18,699
-53% -$407K 0.01% 581
2026
Q1 		$611K Buy
35,217
+1,350
+4% +$25.6K 0.02% 479
2025
Q4 		$638K Buy
33,867
+13,788
+69% +$231K 0.02% 477
2025
Q3 		$292K Buy
20,079
+4,884
+32% +$69.6K 0.01% 747
2025
Q2 		$297K Sell
15,195
-5,422
-26% -$96.3K 0.01% 698
2025
Q1 		$366K Sell
20,617
-2,509
-11% -$54K 0.02% 584
2024
Q4 		$495K Buy
23,126
+9,160
+66% +$223K 0.02% 521
2024
Q3 		$436K Sell
13,966
-2,907
-17% -$72.3K 0.02% 590
2024
Q2 		$262K Sell
16,873
-39,510
-70% -$478K 0.01% 808
2024
Q1 		$597K Buy
56,383
+25,075
+80% +$251K 0.02% 520
2023
Q4 		$376K Sell
31,308
-19,922
-39% -$163K 0.02% 668
2023
Q3 		$359K Sell
51,230
-10,690
-17% -$98.8K 0.02% 579
2023
Q2 		$526K Sell
61,920
-13,097
-17% -$109K 0.03% 498
2023
Q1 		$686K Buy
+75,017
New +$960K 0.04% 409

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Profund Advisors's CDNA Position: Q2 2026 in Review

Profund Advisors reduced its CareDx (CDNA) stake by 53% in Q2 2026, selling an estimated $407K and leaving 16,518 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #581.

Profund Advisors first reported a position in CDNA in Q1 2023 and has held it in 14 quarters since. The position peaked at $686K in Q1 2023. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Profund Advisors held 16,518 shares of CareDx worth $471K as of Q2 2026.
  • Profund Advisors sold 18,699 CareDx shares in Q2 2026, an estimated $407K.
  • CareDx made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #581 holding.
  • Profund Advisors first reported a position in CareDx in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's CareDx position peaked at $686K in Q1 2023.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.